1. Genetics and Genomics
  2. Microbiology and Infectious Disease

Neolithic and Medieval virus genomes reveal complex evolution of Hepatitis B

  1. Ben Krause-Kyora  Is a corresponding author
  2. Julian Susat
  3. Felix M Key
  4. Denise Kühnert
  5. Esther Bosse
  6. Alexander Immel
  7. Christoph Rinne
  8. Sabin-Christin Kornell
  9. Diego Yepes
  10. Sören Franzenburg
  11. Henrike O Heyne
  12. Thomas Meier
  13. Sandra Lösch
  14. Harald Meller
  15. Susanne Friederich
  16. Nicole Nicklisch
  17. Kurt W Alt
  18. Stefan Schreiber
  19. Andreas Tholey
  20. Alexander Herbig
  21. Almut Nebel
  22. Johannes Krause  Is a corresponding author
  1. Kiel University, Germany
  2. Max Planck Institute for the Science of Human History, Germany
  3. University Hospital Zurich, Switzerland
  4. Broad Institute, United States
  5. Heidelberg University, Germany
  6. University of Bern, Switzerland
  7. State Office for Heritage Management and Archaeology Saxony-Anhalt and State Museum of Prehistory, Germany
https://doi.org/10.7554/eLife.36666
Share this article
Cite this article
  1. Ben Krause-Kyora
  2. Julian Susat
  3. Felix M Key
  4. Denise Kühnert
  5. Esther Bosse
  6. Alexander Immel
  7. Christoph Rinne
  8. Sabin-Christin Kornell
  9. Diego Yepes
  10. Sören Franzenburg
  11. Henrike O Heyne
  12. Thomas Meier
  13. Sandra Lösch
  14. Harald Meller
  15. Susanne Friederich
  16. Nicole Nicklisch
  17. Kurt W Alt
  18. Stefan Schreiber
  19. Andreas Tholey
  20. Alexander Herbig
  21. Almut Nebel
  22. Johannes Krause
(2018)
Neolithic and Medieval virus genomes reveal complex evolution of Hepatitis B
eLife 7:e36666.
https://doi.org/10.7554/eLife.36666
  2. Download BibTeX
  3. Download .RIS

Abstract

The hepatitis B virus (HBV) is one of the most widespread human pathogens known today, yet its origin and evolutionary history are still unclear and controversial. Here, we report the analysis of three ancient HBV genomes recovered from human skeletons found at three different archaeological sites in Germany. We reconstructed two Neolithic and one medieval HBV genomes by de novo assembly from shotgun DNA sequencing data. Additionally, we observed HBV-specific peptides using paleo-proteomics. Our results show that HBV circulates in the European population for at least 7000 years. The Neolithic HBV genomes show a high genomic similarity to each other. In a phylogenetic network, they do not group with any human-associated HBV genome and are most closely related to those infecting African non-human primates. These ancient virus forms appear to represent distinct lineages that have no close relatives today and possibly went extinct. Our results reveal the great potential of ancient DNA from human skeletons in order to study the long-time evolution of blood borne viruses.

Data availability

Raw sequence read files have been deposited at the European Nucleotide Archive under accession no. PRJEB24921

The following data sets were generated

Article and author information

Author details

  1. Ben Krause-Kyora

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    For correspondence
    b.krause-kyora@ikmb.uni-kiel.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9435-2872

  2. Julian Susat

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.

  3. Felix M Key

    Department of Archeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2812-6636

  4. Denise Kühnert

    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.

  5. Esther Bosse

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.

  6. Alexander Immel

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.

  7. Christoph Rinne

    Institute of Pre- and Protohistoric Archaeology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.

  8. Sabin-Christin Kornell

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.

  9. Diego Yepes

    Systematic Proteomics and Bioanalytics, Institute for Experimental Medicine, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.

  10. Sören Franzenburg

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.

  11. Henrike O Heyne

    Stanley Center for Psychiatric Research, Broad Institute, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.

  12. Thomas Meier

    Institute for Pre- and Protohistory and Near Eastern Archaeology, Heidelberg University, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.

  13. Sandra Lösch

    Department of Physical Anthropology, Institute of Forensic Medicine, University of Bern, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.

  14. Harald Meller

    State Office for Heritage Management and Archaeology Saxony-Anhalt and State Museum of Prehistory, Halle, Germany
    Competing interests
    The authors declare that no competing interests exist.

  15. Susanne Friederich

    State Office for Heritage Management and Archaeology Saxony-Anhalt and State Museum of Prehistory, Halle, Germany
    Competing interests
    The authors declare that no competing interests exist.

  16. Nicole Nicklisch

    State Office for Heritage Management and Archaeology Saxony-Anhalt and State Museum of Prehistory, Halle, Germany
    Competing interests
    The authors declare that no competing interests exist.

  17. Kurt W Alt

    State Office for Heritage Management and Archaeology Saxony-Anhalt and State Museum of Prehistory, Halle, Germany
    Competing interests
    The authors declare that no competing interests exist.

  18. Stefan Schreiber

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.

  19. Andreas Tholey

    Systematic Proteomics and Bioanalytics, Institute for Experimental Medicine, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.

  20. Alexander Herbig

    Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.

  21. Almut Nebel

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.

  22. Johannes Krause

    Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany
    For correspondence
    krause@shh.mpg.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9144-3920

Funding

European Research Council (APGREID)

  • Johannes Krause

Deutsche Forschungsgemeinschaft (Al 287-7-1)

  • Kurt W Alt

Deutsche Forschungsgemeinschaft (Me 3245/1-1)

  • Harald Meller

Collaborative Research Center (1266)

  • Ben Krause-Kyora

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Our human remains used are prehistoric European specimens. No consent from them can be required. No decedent groups claim responsibility or ancestry to those people.

Copyright

© 2018, Krause-Kyora et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,189
    views
  • 935
    downloads
  • 106
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ben Krause-Kyora
  2. Julian Susat
  3. Felix M Key
  4. Denise Kühnert
  5. Esther Bosse
  6. Alexander Immel
  7. Christoph Rinne
  8. Sabin-Christin Kornell
  9. Diego Yepes
  10. Sören Franzenburg
  11. Henrike O Heyne
  12. Thomas Meier
  13. Sandra Lösch
  14. Harald Meller
  15. Susanne Friederich
  16. Nicole Nicklisch
  17. Kurt W Alt
  18. Stefan Schreiber
  19. Andreas Tholey
  20. Alexander Herbig
  21. Almut Nebel
  22. Johannes Krause
(2018)
Neolithic and Medieval virus genomes reveal complex evolution of Hepatitis B
eLife 7:e36666.
https://doi.org/10.7554/eLife.36666

Share this article

https://doi.org/10.7554/eLife.36666

Categories and tags

Further reading

    1. Computational and Systems Biology
    2. Genetics and Genomics

    Discovering root causal genes with high-throughput perturbations

    Eric V Strobl, Eric Gamazon
    Research Article

    Root causal gene expression levels – or root causal genes for short – correspond to the initial changes to gene expression that generate patient symptoms as a downstream effect. Identifying root causal genes is critical towards developing treatments that modify disease near its onset, but no existing algorithms attempt to identify root causal genes from data. RNA-sequencing (RNA-seq) data introduces challenges such as measurement error, high dimensionality and non-linearity that compromise accurate estimation of root causal effects even with state-of-the-art approaches. We therefore instead leverage Perturb-seq, or high-throughput perturbations with single-cell RNA-seq readout, to learn the causal order between the genes. We then transfer the causal order to bulk RNA-seq and identify root causal genes specific to a given patient for the first time using a novel statistic. Experiments demonstrate large improvements in performance. Applications to macular degeneration and multiple sclerosis also reveal root causal genes that lie on known pathogenic pathways, delineate patient subgroups and implicate a newly defined omnigenic root causal model.

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics

    Transcription: The plusses and minuses of DNA torsion

    Steven Henikoff, David L Levens
    Insight

    A new method for mapping torsion provides insights into the ways that the genome responds to the torsion generated by RNA polymerase II.

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease

    Improved base editing and functional screening in Leishmania via co-expression of the AsCas12a ultra variant, a T7 RNA polymerase, and a cytosine base editor

    Nicole Herrmann May, Anh Cao ... Tom Beneke
    Research Advance

    The ability to analyze the function of all genes in a genome is highly desirable, yet challenging in Leishmania due to a repetitive genome, limited DNA repair mechanisms, and lack of RNA interference in most species. While our introduction of a cytosine base editor (CBE) demonstrated potential to overcome these limitations (Engstler and Beneke, 2023), challenges remained, including low transfection efficiency, variable editing rates across species, parasite growth effects, and competition between deleterious and non-deleterious mutations. Here, we present an optimized approach addressing these issues. We identified a T7 RNAP promoter variant ensuring high editing rates across Leishmania species without compromising growth. A revised CBE single-guide RNAs (sgRNAs) scoring system was developed to prioritize STOP codon generation. Additionally, a triple-expression construct was created for stable integration of CBE sgRNA expression cassettes into a Leishmania safe harbor locus using AsCas12a ultra-mediated DNA double-strand breaks, increasing transfection efficiency by ~400-fold to 1 transfectant per 70 transfected cells. Using this improved system for a small-scale proof-of-principle pooled screen, we successfully confirmed the essential and fitness-associated functions of CK1.2, CRK2, CRK3, AUK1/AIRK, TOR1, IFT88, IFT139, IFT140, and RAB5A in Leishmania mexicana, demonstrating a significant improvement over our previous method. Lastly, we show the utility of co-expressing AsCas12a ultra, T7 RNAP, and CBE for hybrid CRISPR gene replacement and base editing within the same cell line. Overall, these improvements will broaden the range of possible gene editing applications in Leishmania species and will enable a variety of loss-of-function screens in the near future.